English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Cyclooxygenase 2 (COX-2) over expression is involved in the proliferation of mesangial cells in the pathogenesis of glomerulonephritis, and nuclear factor kappa B (NF-κB) signaling participates in the induction of COX-2 gene expression in these cells. This study explores the effect of MG132, a NF-κB proteasome inhibitor, on the pro-inflammatory effect of glomerular COX-2 gene overexpression. A COX-2-overexpressing (COX-2+) mesangial cell line was established in this study. The expression of chemokine (C-C motif) ligand 2 (CCL2) and NF-κB were determined by quantitative real-time polymerase chain reaction (qRT-PCR). The activation of NF-κB was detected by electrophoretic mobility shift assay (EMSA), and the transcriptional activity of NF-kB was determined by luciferase-based reporter gene assay. CCL2 expression in NF-κB-activated cells was suppressed by MG132 (P < 0.05), especially in NF-κB-activated COX-2+ cells. The binding of NF-κB to DNA increased in MG132-treated cells and was accompanied by an increase in NF-κB p50 and p65 subunits. The transcriptional activity of NF-κB in MG132-treated cells significantly decreased, especially in COX-2+ cells (P < 0.05). Therefore, MG132 could reduce pro-inflammatory effects in glomerular mesangial cells with COX-2 gene overexpression and suppress the CCL2 expression by interfering with the dismantling of nuclear NF-κB p65.       Key words: Nuclear factor kappa B (NF-κB) inhibitor, MG132, proteasome inhibitor, cyclooxygenase 2, glomerulonephritis.

MG132 reduces the pro-inflammatory effect of cyclooxygenase 2 (COX-2) on glomerular mesangial cells